Kyriacos Mitrophanous, Chief Innovations Officer at Oxford BioMedica, holds 724.00 shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Kyriacos Mitrophanous Sold $1,841 shares of Oxford BioMedica on Jul 03, 2024 for an estimated value of 5.52K.